These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22226025)

  • 1. Preclinical studies of potential amyloid binding PET/SPECT ligands in Alzheimer's disease.
    Svedberg MM; Rahman O; Hall H
    Nucl Med Biol; 2012 May; 39(4):484-501. PubMed ID: 22226025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease: spect and pet tracers for beta-amyloid imaging.
    Valotassiou V; Archimandritis S; Sifakis N; Papatriantafyllou J; Georgoulias P
    Curr Alzheimer Res; 2010 Sep; 7(6):477-86. PubMed ID: 20455860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of positron-emission tomography/single-photon emission computed tomography imaging probes for in vivo detection of beta-amyloid plaques in Alzheimer's brains.
    Ono M
    Chem Pharm Bull (Tokyo); 2009 Oct; 57(10):1029-39. PubMed ID: 19801854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular imaging of beta-amyloid plaques in the brain].
    Ono M
    Brain Nerve; 2007 Mar; 59(3):233-40. PubMed ID: 17370649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
    J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease.
    Villemagne VL; Rowe CC; Macfarlane S; Novakovic KE; Masters CL
    J Clin Neurosci; 2005 Apr; 12(3):221-30. PubMed ID: 15851069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical properties and human in vivo assessment of 123I-ABC577 as a novel SPECT agent for imaging amyloid-β.
    Maya Y; Okumura Y; Kobayashi R; Onishi T; Shoyama Y; Barret O; Alagille D; Jennings D; Marek K; Seibyl J; Tamagnan G; Tanaka A; Shirakami Y
    Brain; 2016 Jan; 139(Pt 1):193-203. PubMed ID: 26490333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiolabeled bioactive benzoheterocycles for imaging β-amyloid plaques in Alzheimer's disease.
    Yang Y; Cui M
    Eur J Med Chem; 2014 Nov; 87():703-21. PubMed ID: 25305715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG-PET and amyloid-PET imaging: the diverging paths.
    Perani D
    Curr Opin Neurol; 2014 Aug; 27(4):405-13. PubMed ID: 24927239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis.
    Lockhart A; Lamb JR; Osredkar T; Sue LI; Joyce JN; Ye L; Libri V; Leppert D; Beach TG
    Brain; 2007 Oct; 130(Pt 10):2607-15. PubMed ID: 17698496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The contribution of nuclear medicine procedures in the diagnosis of dementia of Alzheimer's type. Imaging beta amyloid plaques].
    Tsolaki M; Trontzos C; Kazis A
    Hell J Nucl Med; 2005; 8(3):187-90. PubMed ID: 16390030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.
    Shin J; Lee SY; Kim SH; Kim YB; Cho SJ
    Neuroimage; 2008 Nov; 43(2):236-44. PubMed ID: 18694837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
    Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
    Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compounds for imaging amyloid-β deposits in an Alzheimer's brain: a patent review.
    Tu P; Fu H; Cui M
    Expert Opin Ther Pat; 2015 Apr; 25(4):413-23. PubMed ID: 25746836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular imaging by PET/SPECT].
    Ono M
    Yakugaku Zasshi; 2009 Mar; 129(3):279-87. PubMed ID: 19252385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging.
    Rokka J; Snellman A; Zona C; La Ferla B; Nicotra F; Salmona M; Forloni G; Haaparanta-Solin M; Rinne JO; Solin O
    Bioorg Med Chem; 2014 May; 22(9):2753-62. PubMed ID: 24702859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET of brain amyloid and tau in mild cognitive impairment.
    Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
    N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of positron emission tomography imaging of beta-amyloid in patients with Alzheimer's disease.
    Xiong KL; Yang QW; Gong SG; Zhang WG
    Nucl Med Commun; 2010 Jan; 31(1):4-11. PubMed ID: 19972633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of positron emission tomography β-amyloid plaque imaging agents.
    Mathis CA; Mason NS; Lopresti BJ; Klunk WE
    Semin Nucl Med; 2012 Nov; 42(6):423-32. PubMed ID: 23026364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.